WestEnd Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
4
| – | – | ﹤0.01% | 142 |
|
|
2025
Q1 | $2.54K | Buy |
4
+3
| +300% | +$1.9K | ﹤0.01% | 135 |
|
|
2024
Q4 | $712 | Hold |
1
| – | – | ﹤0.01% | 151 |
|
|
2024
Q3 | $1.05K | Hold |
1
| – | – | ﹤0.01% | 121 |
|
|
2024
Q2 | $1.05K | Sell |
1
-1
| -50% | -$1.05K | ﹤0.01% | 118 |
|
|
2024
Q1 | $1.93K | Hold |
2
| – | – | ﹤0.01% | 90 |
|
|
2023
Q4 | $1.76K | Hold |
2
| – | – | ﹤0.01% | 94 |
|
|
2023
Q3 | $1.65K | Buy |
+2
| New | +$1.65K | ﹤0.01% | 87 |
|
|
2023
Q2 | – | Hold |
0
| – | -$822 | – | 248 |
|
|
2023
Q1 | – | Sell |
-1
| Closed | -$721 | – | 118 |
|
|
2022
Q4 | $721 | Hold |
1
| – | – | ﹤0.01% | 121 |
|
|
2022
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 127 |
|
|
2022
Q2 | $591 | Buy |
+1
| New | +$591 | ﹤0.01% | 129 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$631 | – | 129 |
|
|
2021
Q4 | $631 | Buy |
+1
| New | +$631 | ﹤0.01% | 143 |
|
|
2021
Q3 | – | Hold |
0
| – | -$558K | – | 130 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 134 |
|